AIM ImmunoTech Operating Expenses 2011-2026 | AIM

Annual Operating Expenses AIM ImmunoTech

2025	2024	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	14.4 M	11.7 M	11 M	10.7 M	12.8 M	15.2 M	18 M	16.1 M	18.6 M	13.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.6 M	10.7 M	14.2 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 9.33	1.41 %	$ 603 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.87	-2.13 %	$ 6.4 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.38	0.81 %	$ 3.71 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Galapagos NV GLPG	709 M	$ 28.15	1.04 %	$ 2.69 B	Belgium
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	1.64 B	$ 8.22	3.92 %	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	462 M	$ 30.95	-0.34 %	$ 1.78 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
ImmuCell Corporation ICCC	9.8 M	$ 8.43	-0.12 %	$ 76.1 M	USA
InflaRx N.V. IFRX	52.4 M	$ 1.97	-0.51 %	$ 152 M	Germany
Incyte Corporation INCY	1.62 B	$ 98.55	-0.55 %	$ 19.2 B	USA
InMed Pharmaceuticals INM	9.78 M	$ 0.71	1.27 %	$ 1.74 M	Canada
Innoviva INVA	144 M	$ 22.97	-0.35 %	$ 1.55 B	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	512 M	$ 104.02	2.41 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Jaguar Health JAGX	36 M	$ 7.34	-6.79 %	$ 17.1 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
KalVista Pharmaceuticals KALV	161 M	$ 26.68	0.02 %	$ 1.44 B	Britain
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	63 M	$ 1.45	-2.68 %	$ 235 M	France
Kamada Ltd. KMDA	69 K	$ 8.16	0.68 %	$ 260 M	Israel
Krystal Biotech KRYS	228 M	$ 260.24	0.11 %	$ 7.53 B	USA
Kazia Therapeutics Limited KZIA	8.82 M	$ 13.58	9.34 %	$ 1.8 B	Australia
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Ligand Pharmaceuticals Incorporated LGND	115 M	$ 220.06	-2.13 %	$ 4.02 B	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.94	-1.67 %	$ 4.84 M	Israel
Liquidia Corporation LQDA	59.6	$ 38.41	0.67 %	$ 3.31 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	85.5 M	$ 4.08	0.62 %	$ 436 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 23.15	3.49 %	$ 2.95 B	USA